COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN THE TREATMENT OF OPEN TIBIA FRACTURES IN THE NETHERLANDS

被引:0
|
作者
Van Genugten, M. [1 ]
Chhabra, A. [2 ]
Alt, V [3 ]
机构
[1] Medtron Trading NL BV, Heerlen, Netherlands
[2] Medtron Europe SA, Tolochenaz, Switzerland
[3] Univ Hosp Giessen Marburg, Brackenheim, Germany
关键词
D O I
10.1016/S1098-3015(10)66795-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A544 / A544
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of rhBMP-2 in the treatment of open tibia fractures in Sweden and Denmark
    Alt, V
    Chhabra, A.
    Nicklasson, L.
    Greenberg, D.
    Schnettler, R.
    VALUE IN HEALTH, 2007, 10 (03) : A183 - A183
  • [2] Comparing the cost-effectiveness of rhBMP-2 in the treatment of open tibia fractures in Germany, France, and UK
    Chhabra, A.
    Bentley, A.
    Oliver, E.
    Salaun, B.
    Greenberg, D.
    Alt, V
    VALUE IN HEALTH, 2006, 9 (06) : A379 - A380
  • [3] A COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN SPINE FUSION SURGERY IN THE NETHERLANDS
    Van Genugten, M.
    Chhabra, A.
    Alt, V
    VALUE IN HEALTH, 2008, 11 (06) : A532 - A533
  • [4] A cost-effectiveness analysis of rhBMP-2 in spine fusion surgery in Sweden and Denmark
    Chhabra, A.
    Nicklasson, L.
    Greenberg, D.
    Alt, V
    VALUE IN HEALTH, 2007, 10 (03) : A97 - A97
  • [5] The Use of rhBMP-2 for the Treatment of Congenital Pseudarthrosis of the Tibia A Case Series
    Richards, B. Stephens
    Oetgen, Matthew E.
    Johnston, Charles E.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2010, 92A (01): : 177 - 185
  • [6] Savings of the use of rhBMP-2 in open tibia fractures for European health care systems from a payer and societal perspective
    Alt, V
    Bentley, A.
    Schnettler, R.
    VALUE IN HEALTH, 2007, 10 (03) : A184 - A184
  • [7] rhBMP-2 and Intramedullary Fixation in Congenital Pseudarthrosis of the Tibia
    Richards, B. Stephens
    Anderson, Terrence D.
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2018, 38 (04) : 230 - 238
  • [8] Use of antibiotic coated intramedullary nails in open tibia fractures: A European medical resource use and cost-effectiveness analysis
    Franz, D.
    Raschke, M.
    Giannoudis, P. V.
    Leliveld, M.
    Metsemakers, W. J.
    Verhofstad, M. H. J.
    Craig, J. A.
    Shore, J.
    Smith, A.
    Muehlendyck, C.
    Kerstan, M.
    Fuchs, T.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2021, 52 (07): : 1 - 8
  • [9] Cost-benefit analysis of the use of rhBMP-2 in open tibial fractures. Savings from a health insurer's perspective
    Alt, V.
    Bitschnau, A.
    Schnettler, R.
    UNFALLCHIRURG, 2006, 109 (06): : 463 - 470
  • [10] Cost-effectiveness of fosavancet in the treatment of osteoporosis in the Netherlands
    Jansen, J. P.
    Shavit, O.
    Bergman, G.
    Sen, S. S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S259 - S259